Embryo Health Study

Part of paid clinical trials in North Brunswick, New Jersey.

Sponsor
Genomic Prediction Inc.
Study ID
NCT04528498
Status
Recruiting
Apply to this trial

Conditions

  • Hereditary Diseases
  • Infertility

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Preimplantation Genetic Testing — OTHER
    Embryo biopsies will undergo preimplantation genetic testing for aneuploidies as per standard of care, and polygenic disease risk (PGT-P) will be computed for these samples.

Study Details

This study intends to determine the patients' perception and motivation to obtain additional information on their preimplantation embryos' risks of polygenic disorders. Patients undergoing IVF and genetic testing on their embryos for aneuploidies will be given the option to obtain information of their embryos' polygenic disease risk after receiving genetic counseling.

Key Dates

Start date
Dec 1, 2020
Status verified
Aug 2024
Primary completion
Dec 1, 2025
Completion
Dec 1, 2025

Study Design

Enrollment
500 participants (estimated)

Primary Outcome Measure

Patients' interest in Preimplantation Genetic Testing for Polygenic Disorders [ Time Frame: 2 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Genomic Prediction Clinical LaboratoryNorth BrunswickNew Jersey08902
Talia Metzgar, RN
[email protected]
Bhavini Rana
[email protected]
Nathan Treff, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in North Brunswick, NJ

By research site
Genomic Prediction Clinical Laboratory· North Brunswick, NJ

Related Studies